The average one-year price target for Werewolf Therapeutics (NasdaqGS:HOWL) has been revised to $5.30 / share. This is a ...

Werewolf Therapeutics, Inc. (NASDAQ:HOWL) is included on our list of stocks under $1 that will explode. On December 18, 2025, ...

Award-winning actor Leonardo DiCaprio and respected environmental activist Jane Goodall will executive produce a live-action movie about a dog and young wolf’s survival journey, set to be told through ...

Investors might want to bet on Werewolf Therapeutics, Inc. (HOWL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings ...

Werewolf Therapeutics, Inc. develops modified cytokines for cancer treatment, including WTX-124, a modified IL-2, and WTX-330, a modified IL-12. Xilio Therapeutics out-licensed their modified IL-12 to ...

Howling is loudest when a close companion is taken away, study shows. Sept. 1, 2013— -- The most ferocious predator in the forest, despised by cattle ranchers and feared by humans and nearly ...

Werewolf Therapeutics (NASDAQ:HOWL) just reported results for the second quarter of 2024. Werewolf Therapeutics reported earnings per share of -43 cents. This was below the analyst estimate for EPS of ...